Differences in Tacrolimus Troughs and Doses Between Caucasians and African Americans with Two CYP3A5 Loss-of-Function Alleles: Looking Beyond CYP3A5 Expression.

被引：0
|
作者：
Oetting, W. [1 ]
Schladt, D. [2 ,3 ]
Guan, W. [1 ]
Remmel, R. [1 ]
Dorr, C. [2 ,3 ]
Sanghavi, K. [1 ]
Matas, A. [1 ]
Mannon, R. [4 ]
Israni, A. [2 ,3 ]
Jacobson, P. [1 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
[2] Hennepin Cty Med Ctr, Minneapolis, MN USA
[3] Minneapolis Med Res Fdn Inc, Minneapolis, MN USA
[4] Univ Alabama Birmingham, Birmingham, AL USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C251
引用
收藏
页码：681 / 682
页数：2
相关论文
共 50 条
  • [41] Association between renal function and CYP3A5 gene polymorphisms in Asian heart transplantation with tacrolimus-based regimen
    Wang, Tzu
    Wu, Chia-Wei
    Chen, Chien-Hao
    Lin, Shin-Yi
    Chen, Yih-Sharng
    Huang, Chih-Fen
    TRANSPLANTATION, 2024, 108 (09) : 722 - 722
  • [42] No ethnic difference between Caucasian and Japanese hepatic samples in the expression frequency of CYP3A5 and CYP3A7 proteins
    Tateishi, T
    Watanabe, M
    Moriya, H
    Yamaguchi, S
    Sato, T
    Kobayashi, S
    BIOCHEMICAL PHARMACOLOGY, 1999, 57 (08) : 935 - 939
  • [43] Higher Number of Tacrolimus Dose Adjustments and Trough Level Measurements in Kidney Transplant Recipients with CYP3A5*1 Alleles
    Reininger, K.
    Onyeaghala, G.
    Anderson-Haag, T.
    Wu, B.
    Guan, W.
    Dorr, C. R.
    Remmel, R.
    Mannon, R.
    Matas, A.
    Oetting, W.
    Israni, A.
    Stahler, P.
    Jacobson, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 387 - 387
  • [44] Significant association between CYP3A5 polymorphism and blood concentration of tacrolimus in patients with connective tissue diseases
    Tanaka, Kosuke
    Terao, Chikashi
    Ohmura, Koichiro
    Takahashi, Meiko
    Nakashima, Ran
    Imura, Yoshitaka
    Yoshifuji, Hajime
    Yukawa, Naoichiro
    Usui, Takashi
    Fujii, Takao
    Mimori, Tsuneyo
    Matsuda, Fumihiko
    JOURNAL OF HUMAN GENETICS, 2014, 59 (02) : 107 - 109
  • [45] Significant association between CYP3A5 polymorphism and blood concentration of tacrolimus in patients with connective tissue diseases
    Kosuke Tanaka
    Chikashi Terao
    Koichiro Ohmura
    Meiko Takahashi
    Ran Nakashima
    Yoshitaka Imura
    Hajime Yoshifuji
    Naoichiro Yukawa
    Takashi Usui
    Takao Fujii
    Tsuneyo Mimori
    Fumihiko Matsuda
    Journal of Human Genetics, 2014, 59 : 107 - 109
  • [46] CYP3A5 polymorphism is associated with differences on gene expression and cholesterol-lowering response to atorvastatin
    Willrich, M. V.
    Hirata, M. H.
    Bernik, M. M.
    Dorea, E. L.
    Bertolami, M. C.
    Faludi, A.
    Hirata, R. D.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A151 - A151
  • [47] Association between CYP3A4, CYP3A5 and ABCB1 genotype and tacrolimus treatment outcomes among allogeneic HSCT patients
    Ho, Teresa T.
    Perkins, Janelle B.
    Gonzalez, Rebecca
    Hicks, James Kevin
    Martinez, Ronald Alvarez
    Duranceau, Katie
    North, Brianna
    Kim, Jongphil
    Teer, Jamie K.
    Yao, Jiqiang
    Yoder, Sean J.
    Nishihori, Taiga
    Bejanyan, Nelli
    Pidala, Joseph
    Elmariah, Hany
    PHARMACOGENOMICS, 2024, 25 (01) : 29 - 40
  • [48] Genetically predicted CYP3A5 expression influences changes with time in tacrolimus pharmacokinetics but not long-term outcomes
    Ng, Fu Liang
    Holt, David W.
    MacPhee, Iain A. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 636 - 636
  • [49] Differences in CYP3A5*3 genotype distribution and combinations with other polymorphisms between Spaniards and other Caucasian populations
    Gervasini, G
    Vizcaino, S
    Gasiba, C
    Carrillo, JA
    Benitez, J
    THERAPEUTIC DRUG MONITORING, 2005, 27 (06) : 819 - 821
  • [50] Influence of CYP3A5 genetic differences in tacrolimus on quantitative interstitial fibrosis and long-term graft function in kidney transplant recipients
    Komine, Naoki
    Satoh, Shigeru
    Saito, Mitsuru
    Numakura, Kazuyuki
    Inoue, Takamitsu
    Tsuruta, Hiroshi
    Narita, Shintaro
    Komatsuda, Atsushi
    Nanjo, Hiroshi
    Kagaya, Hideaki
    Niioka, Takenori
    Miura, Masatomo
    Mitobe, Yoko
    Habuchi, Tomonori
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 58 : 57 - 63
12345